Out-of-Pocket Costs for MS Drugs; Part 4 of the Thunderclap Headache Series
Neurology® Podcast
00:00
What's the Best Strategy for the Practice of Neurology?
The federal government cannot directly negotiate prices with the pharmaceudical industry. The choice of d m t that you discuss with a patient is often constrained by, you know, theur insurance plan. And neurologists and their staff are forced to deal with these kind of hurdles just to make sure patients have access.
Transcript
Play full episode
